Hôpital Bretonneau

corporate_fareorganization

Hôpital Bretonneau

- Funding / Projects
  (22)

22 Projects, page 1 of 5

Adaptive radiotherapy to decrease xerostomia in oropharynx carcinoma: cumulative dose model and predictors of toxicity
assignment_turned_inProject2012 - 2016Partners:Centre Antoine Lacassagne, Centre Eugène Marquis, Centre Oscar Lambret, Centre Hospitalier Universitaire de Poitiers, Centre François Baclesse +2 partners
Centre Antoine Lacassagne,
Centre Eugène Marquis,
Centre Oscar Lambret,
Centre Hospitalier Universitaire de Poitiers,
Centre François Baclesse,
Hôpital Bretonneau,
INSERM U650
Funder: Institut National du Cancer Project Code: INCa-4924
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
A randomized phase III study of Velcade-Melphalan 200 conditioning regimen versus Melphalan 200 for frontline transplant eligible patients with multiple myeloma
assignment_turned_inProjectPartners:CHM, Délégation à la Recherche et à lInnovation - CHU Angers, Hôpital Morvan, Centre Hospitalier de Colmar, Groupe Hospitalier Henri Mondor - Albert Chenevier +22 partners
CHM,
Délégation à la Recherche et à lInnovation - CHU Angers,
Hôpital Morvan,
Centre Hospitalier de Colmar,
Groupe Hospitalier Henri Mondor - Albert Chenevier,
Centre Hospitalier Universitaire de Clermont-Ferrand,
Hôpital Claude Huriez,
CEA Fontenay-aux-Roses,
Centre Hospitalier Universitaire de Rennes,
Centre Léon Bérard,
Centre Hospitalier René Dubos,
Hôpital Jean Minjoz,
Groupe Hospitalier Cochin,
Hôpital Avicenne,
Hôpital Purpan,
Hôpitaux de Brabois Adultes-Enfants,
Centre Hospitalier Universitaire de Saint-Étienne,
Hôpital d'Instruction des Armées (HIA) Percy,
Centre Hospitalier Victor Dupouy,
Hôpital Bretonneau,
Centre Hospitalier de la Côte Basque,
Hôpital le Bocage,
HUS,
Hôpital Saint-Louis,
Centre Hospitalier Universitaire de la Réunion,
Hôpital Dupuytren,
Hôpital Notre-Dame de Bon Secours
Funder: Institut National du Cancer Project Code: INCa-DGOS-7292
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
Etude de phase III randomisée, en double aveugle, multicentrique, évaluant l’efficacité préventive et curative du laser basse énergie (100mW, 658 nm), sur les mucites radio et chimio-induites des patients traités pour un cancer de la sphère ORL de stade III-IV.
assignment_turned_inProjectPartners:Hôpital Bretonneau, HCL, CHLS, Institut de Cancérologie de l'Ouest, Centre Antoine Lacassagne
Hôpital Bretonneau,
HCL,
CHLS,
Institut de Cancérologie de l'Ouest,
Centre Antoine Lacassagne
Funder: Institut National du Cancer Project Code: INCa-DGOS-298
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
CHONRAD - Evaluation of efficacy and safety of Évérolimus as neo-adjuvant therapy in chondrosarcoma patients: phase IIa, prospective, multicentric, open-label.
assignment_turned_inProjectPartners:Hôpital Purpan, Hôpital de la Conception, Institut Gustave Roussy, Centre Léon Bérard, Hôpital Roger Salengro +5 partners
Hôpital Purpan,
Hôpital de la Conception,
Institut Gustave Roussy,
Centre Léon Bérard,
Hôpital Roger Salengro,
Hôpital Bretonneau,
Institut de Cancérologie de Lorraine,
ICM-VAL D'AURELLE,
Centre Hospitalier Universitaire de la Réunion,
CHU Marseille - Hôpital la Timone
Funder: Institut National du Cancer Project Code: INCa-DGOS-3761
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
COULD POSITRON EMISSION TOMOGRAPHY WITH RADIOLABELLED 3’-DEOXY-3’(18)F-FLUOROTHYMIDINE BE A THERANOSTIC TOOL DURING ERLOTINIB TREATMENT IN NON-SMALL CELL LUNG CANCER PATIENTS?
assignment_turned_inProjectPartners:Hôpital Saint-Antoine, Hôpital d'Instruction des Armées (HIA) Percy, Centre Hospitalier Universitaire d'Angers, Hôpital Bretonneau, Hôpital Charles-Nicolle +3 partners
Hôpital Saint-Antoine,
Hôpital d'Instruction des Armées (HIA) Percy,
Centre Hospitalier Universitaire d'Angers,
Hôpital Bretonneau,
Hôpital Charles-Nicolle,
Hôpital Pellegrin,
Hôpital Larrey -CHU Toulouse,
Hôpitaux de Brabois Adultes-Enfants
Funder: Institut National du Cancer Project Code: INCa-DGOS-5631
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu

chevron_left
1
2
3
4
5
chevron_right

Hôpital Bretonneau

Hôpital Bretonneau

22 Projects, page 1 of 5

Adaptive radiotherapy to decrease xerostomia in oropharynx carcinoma: cumulative dose model and predictors of toxicity

A randomized phase III study of Velcade-Melphalan 200 conditioning regimen versus Melphalan 200 for frontline transplant eligible patients with multiple myeloma

Etude de phase III randomisée, en double aveugle, multicentrique, évaluant l’efficacité préventive et curative du laser basse énergie (100mW, 658 nm), sur les mucites radio et chimio-induites des patients traités pour un cancer de la sphère ORL de stade III-IV.

CHONRAD - Evaluation of efficacy and safety of Évérolimus as neo-adjuvant therapy in chondrosarcoma patients: phase IIa, prospective, multicentric, open-label.

COULD POSITRON EMISSION TOMOGRAPHY WITH RADIOLABELLED 3’-DEOXY-3’(18)F-FLUOROTHYMIDINE BE A THERANOSTIC TOOL DURING ERLOTINIB TREATMENT IN NON-SMALL CELL LUNG CANCER PATIENTS?

Loading